Search Results

You are looking at 1 - 1 of 1 items for

  • Author: M. Hannah x
  • Refine by Access: All content x
Clear All Modify Search
Restricted access

M. G. Castro, J. Brooke, A. Bullman, M. Hannah, B. P. Glynn, and P. J. Lowry


The mouse corticotrophic tumour cell line AtT-20 naturally synthesizes pro-opiomelanocortin (POMC) which is proteolytically processed to N-POMC(1–76), ACTH, β-lipotrophin and β-endorphin. The processed products are stored in secretory vesicles and released upon stimulation with specific secretagogues. ArT-20 cells which have been stably transfected with the human corticotrophin-releasing hormone (CRH) gene store and secrete immunoreactive CRH. The present results demonstrate that the CRH precursor is proteolytically processed in the transfected cells to yield the 41 amino acid neuropeptide CRH(1–41). On stimulation with the secretagogue noradrenaline, CRH(1–41) was released into the medium, while the precursor was not. Whilst treatment of wild-type ArT-20 cells with exogenous CRH(1–41) (1 nm) caused a fourfold stimulation of ACTH release above basal levels, the peptide had no effect on ACTH release from the stably transfected cells R1 and R4. These results suggest that the endogenous CRH produced by the transfected R1 and R4 cells may cause down-regulation of their CRH receptors, and thus exogenous CRH cannot cause further stimulation of ACTH release in these cells. We propose that the CRH precursor is correctly processed in the transfected AtT-20 cells (R1 and R4) and that the foreign prohormone is sorted into the secretory pathway.